Thai Cancer Anemia Survey in Chulalongkorn Hospital

Official Title: “Thai Cancer Anemia Survey in Chulalongkorn Hospital”

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Intervention(s) in this Clinical Trial

• Other: Adult Cancer Patients
  • Tracking anemia management in Adult Cancer Patients

Arms, Groups and Cohorts in this Clinical Trial

• : 001
  • Adult Cancer Patients Tracking anemia management in Adult Cancer Patients

Primary Measures

• Number of patients that have anemia during cancer therapy
  • Time Frame: 6 months
    Safety Issue?: No

Secondary Measures

• Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia
  • Time Frame: 6 months
    Safety Issue?: No

Inclusion Criteria:

• Patients with cancer

Exclusion Criteria:

• None

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Investigator: Janssen-Cilag Ltd.,Thailand Industry

Overall Clinical Trial Officials and Contacts

Janssen-Cilag Ltd Clinical Trial Study Director Janssen-Cilag Ltd.  

Information obtained from ClinicalTrials.gov on February 09, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01018043

Study ID Number: CR011731

ClinicalTrials.gov Identifier: NCT01018043

Health Authority: Thailand: Ministry of Public Health